UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunogenicity of biologic therapies for migraine: a review of current evidence

Journal of headache and pain, 2021-01, Vol.22 (1), p.3-8, Article 3

2021

Volltextzugriff (PDF)

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States

Journal of headache and pain, 2021-12, Vol.22 (1), p.156-156, Article 156

2021

Volltextzugriff (PDF)

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

Journal of headache and pain, 2021-11, Vol.22 (1), p.141-141, Article 141

2021

Volltextzugriff (PDF)

A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States

Journal of headache and pain, 2022-05, Vol.23 (1), p.54-54, Article 54

2022

Volltextzugriff (PDF)

Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide's motor-stimulating and prosecretory function in the intestine

Frontiers in physiology, 2022-11, Vol.13, p.1067274-1067274

2022

Volltextzugriff (PDF)

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

Journal of headache and pain, 2022-05, Vol.23 (1), p.57-57, Article 57

2022

Volltextzugriff (PDF)

Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive Response

Pain and therapy, 2024-06, Vol.13 (3), p.511-532

2024

Volltextzugriff (PDF)

Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study

Cephalalgia reports, 2024-01, Vol.7

2024

Volltextzugriff (PDF)

Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments

Journal of clinical medicine, 2022-07, Vol.11 (15), p.4359

2022

Volltextzugriff (PDF)

A Review of Complementary and Alternative Medicine Use Among U.S. Adults with Headache or Migraine: Results from the 2012 National Health Interview Survey

Headache, 2017-09, Vol.57 (8), p.1284-1285

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

A Review of HIV and Headache: A Cross‐Sectional Study

Headache, 2017-11, Vol.57 (10), p.1631-1632

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States

Headache, 2017-10, Vol.57 (9), p.1451-1452

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the American Migraine Prevalence and Prevention Study

Headache, 2017-07, Vol.57 (7), p.1156-1157

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

A Review of CGRP and Its Receptors

Headache, 2017-04, Vol.57 (4), p.670-671

Krasenbaum, Lynda J

2017

Volltextzugriff (PDF)

A Review of Vomiting and Migraine‐Related Clinical Parameters in Pediatric Migraine

Headache, 2017-06, Vol.57 (6), p.979-980

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

A Review of Radiofrequency for Arteriovenous Malformations and the Impact on Headache

Headache, 2017-05, Vol.57 (5), p.812-813

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

A Review of “Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study”

Headache, 2017-03, Vol.57 (3), p.500-501

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

A Review of “Hormonal Contraceptives and Migraine With Aura – Is There Still a Risk?”

Headache, 2017-02, Vol.57 (2), p.313-313

Krasenbaum, Lynda J

2017

Volltextzugriff (PDF)

A Review of “Peripheral Nerve Blocks for the Treatment of Headache in Older Adults: A Retrospective Study”

Headache, 2017-01, Vol.57 (1), p.128-128

Krasenbaum, Lynda J

2017

Volltextzugriff (PDF)

Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review

Medicine (Baltimore), 2023-06, Vol.102 (23), p.e33874-e33874

2023

Volltextzugriff (PDF)

Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study

Headache, 2023-07, Vol.63 (7), p.908-916

2023

Volltextzugriff (PDF)

Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials”. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819–828. Epublished November 2020

Naunyn-Schmiedeberg's archives of pharmacology, 2021-11, Vol.394 (11), p.2343-2346

2021

Volltextzugriff (PDF)

A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the U nited S tates

Headache, 2017-10, Vol.57 (9), p.1451-1452

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the A merican Migraine Prevalence and Prevention Study

Headache, 2017-07, Vol.57 (7), p.1156-1157

Krasenbaum, Lynda J.

2017

Volltextzugriff (PDF)

Reductions in Migraine-related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: Results of a Long-term US Claims Database Analysis (P12-2.002)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunogenicity of biologic therapies for migraine: a review of current evidence

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States

Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide's motor-stimulating and prosecretory function in the intestine

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive Response

Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study

Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments

A Review of Complementary and Alternative Medicine Use Among U.S. Adults with Headache or Migraine: Results from the 2012 National Health Interview Survey

A Review of HIV and Headache: A Cross‐Sectional Study

A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States

A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the American Migraine Prevalence and Prevention Study

A Review of CGRP and Its Receptors

A Review of Vomiting and Migraine‐Related Clinical Parameters in Pediatric Migraine

A Review of Radiofrequency for Arteriovenous Malformations and the Impact on Headache

A Review of “Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study”

A Review of “Hormonal Contraceptives and Migraine With Aura – Is There Still a Risk?”

A Review of “Peripheral Nerve Blocks for the Treatment of Headache in Older Adults: A Retrospective Study”

Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review

Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study

Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials”. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819–828. Epublished November 2020

A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the U nited S tates

A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the A merican Migraine Prevalence and Prevention Study

Reductions in Migraine-related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: Results of a Long-term US Claims Database Analysis (P12-2.002)

Suchergebnisse filtern